Format

Send to

Choose Destination
Crit Care. 2000;4(5):302-8. Epub 2000 Jul 31.

Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care.

Author information

1
Department of Intensive Care, St George's Hospital, London, UK.

Abstract

STATEMENT OF FINDINGS:

The respiratory effects of dexmedetomidine were retrospectively examined in 33 postsurgical patients involved in a randomised, placebo-controlled trial after extubation in the intensive care unit (ICU). Morphine requirements were reduced by over 50% in patients receiving dexmedetomidine. There were no differences in respiratory rates, oxygen saturations, arterial pH and arterial partial carbon dioxide tension (PaCO2) between the groups. Interestingly the arterial partial oxygen tension (PaO2) : fractional inspired oxygen (FIO2) ratios were statistically significantly higher in the dexmedetomidine group. Dexmedetomidine provides important postsurgical analgesia and appears to have no clinically important adverse effects on respiration in the surgical patient who requires intensive care.

PMID:
11056756
PMCID:
PMC29047
DOI:
10.1186/cc712
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center